Profile Details

Create Project

★★★★★

☆☆☆☆☆

USD 60 /hr

★★★★★

☆☆☆☆☆

Hire Dr. Muhammad K.

Australia

USD 60 /hr

Motivated life scientist with a proven record of academic publications and good writing skills.

Profile Summary

I have a strong aptitude to integrate and explain complex ideas in logical and compelling ways. I therefore have 16 academic publications in international peer-reviewed journal, most of them are Q1-ranked. I am passionate about producing freelancing projects in areas covering pharmaceuticals, oncology, virology, clinical studies, nutraceuticals, and healthcare.

Subject Matter Expertise

• ★ Medicinal Chemistry
• ★ Drug Design
• ★ Drug Development
• ☆ Physical Chemistry
• ☆ Molecular Modeling
• ☆ Computational Chemistry
• ☆ Pharmaceutical Sciences
• ☆ Research

Services

• Writing
• Research
• Data & AI

Writing Clinical Trial Documentation, Technical Writing

Research Systematic Literature Review

Data & AI Data Visualization

Work Experience

Researcher

National Research Centre

June 2008 - Present

Monash University

January 2020 - March 2020

Researcher

Swinburne University of Technology

September 2014 - October 2019

Education

PhD (Chemistry)

Swinburne University, Australia

September 2014 - October 2018

Certifications

• Certification details not provided.

Publications

JOURNAL ARTICLE

(2020). Theoretical study of the geometric and electronic characterization of carbendazim-based drug (Nocodazole) . Heliyon.

Ahmed A. Al-Karmalawy and Muhammad Khattab(2020). Molecular modelling of mebendazole polymorphs as a potential colchicine binding site inhibitor . New Journal of Chemistry. 44. (33). p. 13990--13996. Royal Society of Chemistry ({RSC})

(2019). Structural and Spectroscopic Study of the Tyrosine Kinase Inhibitor PD-153035 .

Galal, S.A., Khattab, M., Shouman, S.A., Ramadan, R., Kandil, O.M., Kandil, O.M., Tabll, A., El Abd, Y.S., El-Shenawy, R., Attia, Y.M., et al.(2018). Part III: Novel checkpoint kinase 2 (Chk2) inhibitors; design, synthesis and biological evaluation of pyrimidine-benzimidazole conjugates . European Journal of Medicinal Chemistry. 146. p. 687-708.

Conformational Plasticity in Tyrosine Kinase Inhibitor–Kinase Interactions Revealed with Fluorescence Spectroscopy and Theoretical Calculations @article{doi:10.1021/acs.jpcb.8b01530, author= {Khattab, Muhammad and Wang, Feng and Clayton, Andrew H. A.}, title= {Conformational Plasticity in Tyrosine Kinase Inhibitor–Kinase Interactions Revealed with Fluorescence Spectroscopy and Theoretical Calculations}, journal= {The Journal of Physical Chemistry B}, volume= {122}, number= {17}, pages= {4667-4679}, year= {2018}, doi= {10.1021/acs.jpcb.8b01530}, note= {PMID: 29629773}, URL= {https://doi.org/10.1021/acs.jpcb.8b01530 }, eprint= {https://doi.org/10.1021/acs.jpcb.8b01530 }} . The Journal of Physical Chemistry B.

Van Dongen, M., Khattab, M., Clayton, A.H.A., Wang, F.(2017). Exploring the optical reporting characteristics of drugs: UV-Vis spectra and conformations of the tyrosine kinase inhibitor SKF86002 . New Journal of Chemistry. 41. (23). p. 14567-14573.

(2017). Micro-solvation of tyrosine-kinase inhibitor AG1478 explored with fluorescence spectroscopy and computational chemistry .

Khattab, Muhammad, Van Dongen, Madeline, Wang, Feng, Clayton, Andrew H A(2017). Solvatochromism and linear solvation energy relationship of the kinase inhibitor SKF86002 . Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy. 170. p. 226-33.

Khattab, M., Wang, F., Clayton, A.H.A.(2017). A pH-induced conformational switch in a tyrosine kinase inhibitor identified by electronic spectroscopy and quantum chemical calculations . Scientific Reports. 7. (1).

Khattab, M., Van Dongen, M., Wang, F., Clayton, A.H.A.(2017). Solvatochromism and linear solvation energy relationship of the kinase inhibitor SKF86002 . Spectrochimica Acta - Part A: Molecular and Biomolecular Spectroscopy. 170. p. 226-233.

Khattab, Muhammad, Wang, Feng, Clayton, Andrew H. A.(2016). UV-Vis spectroscopy and solvatochromism of the tyrosine kinase inhibitor AG-1478 . Spectrochimica Acta Part a-Molecular and Biomolecular Spectroscopy. 164. p. 128-132.

Khattab, M., Wang, F., Clayton, A.H.A.(2016). UV-Vis spectroscopy and solvatochromism of the tyrosine kinase inhibitor AG-1478 . Spectrochimica Acta - Part A: Molecular and Biomolecular Spectroscopy. 164. p. 128-132.

Khattab, Muhammad, Galal, Shadia A., Andreadaki, Fotini, Chrysina, Evangelia D., Praly, Jean-Pierre, Ragab, Fatma A. F., El Diwani, Hoda I.(2016). Synthesis of (benzimidazol-2-yl)aniline derivatives as glycogen phosphorylase inhibitors . Bioorganic & Medicinal Chemistry. 24. (21). p. 5423-5430.

Galal, S.A., Khattab, M., Andreadaki, F., Chrysina, E.D., Praly, J.-P., Ragab, F.A.F., El Diwani, H.I.(2016). Synthesis of (benzimidazol-2-yl)aniline derivatives as glycogen phosphorylase inhibitors . Bioorganic and Medicinal Chemistry. 24. (21). p. 5423-5430.

Khattab, Muhammad, Chatterjee, Subhojyoti, Clayton, Andrew H. A., Wang, Feng(2016). Two conformers of a tyrosine kinase inhibitor (AG-1478) disclosed using simulated UV-Vis absorption spectroscopy . New Journal of Chemistry. 40. (10). p. 8296-8304.

Khattab, M., Chatterjee, S., Clayton, A.H.A., Wang, F.(2016). Two conformers of a tyrosine kinase inhibitor (AG-1478) disclosed using simulated UV-Vis absorption spectroscopy . New Journal of Chemistry. 40. (10). p. 8296-8304.

Khattab, Muhammad, Galal, Shadia A., Ragab, Fatma A. F., El Diwani, Hoda I.(2013). Different synthetic routes to 4-(1H-benzo[d]imidazol-2-yl)aniline . Research on Chemical Intermediates. 39. (7). p. 2917-2923.

Khattab, M., Galal, S.A., Ragab, F.A.F., El Diwani, H.I.(2013). Different synthetic routes to 4-(1H-benzo[d]imidazol-2-yl)aniline . Research on Chemical Intermediates. 39. (7). p. 2917-2923.

Khattab, MK, Ragab, F, Galal, SA, El Diwani, HI(2012). Synthesis of 4-(1H-benzo [d] imidazol-2-yl) aniline derivatives of expected anti-HCV activity. Int J Res Pharm Chem. 2. p. 937-46.